View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . November 17th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Adverse Drug Reactions - Dermipsor Reports Positive Phase 2b Results Showing Efficacy and Synergy of its Leading Product DPS-101, a Non- Steroidal Combination Drug to Treat Psoriasis the data showed statistical significant efficacy in most arms.

Alexza Pharmaceuticals, Inc. - Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates

Atopic Dermatitis - BioCis Pharma begins Phase IIa Trial in Atopic Dermatitis

Clinical Trial Research - Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue

Diarrhea - Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)

Metabasis Therapeutics, Inc. - Results from Metabasis' Phase 2a Clinical Trial for MB07803 Show Statistically Significant Reductions in FPG, as Well as Safety and Tolerability

Osteoarthritis - NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study

Schering-Plough Corporation - Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients

Smallpox Vaccines - Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)

Angiogenesis - New angiogenesis research from M. Pinter and colleagues discussed

Breast Cancer - Studies from B. Mlineritsch and colleagues reveal new findings on breast cancer

Cancer - Reports outline cancer study results from University of Heidelberg

Cancer - Research results from National University update understanding of cancer

Cancer - Scientists at University of Texas target cancer

Cancer - Scientists at University of Wisconsin describe research in cancer

Clinical Trial Research - New clinical trial research from Cleveland Clinic described

Clinical Trial Research - Studies from Erasmus University in the area of clinical trial research described

Colon Cancer - Research results from M.G. Zampino and colleagues update understanding of colon cancer

Enzyme Research - Research from L.Q.M. Chow and co-researchers in the area of enzyme research published

Fusion Proteins - Researchers from Third Military Medical University report recent findings in fusion proteins

Gastric Cancer - Research on gastric cancer discussed by scientists at University of Ulsan

Glioblastoma - New glioblastoma research reported from C.E. Fadul and co-authors

Glioma - Scientists at Nagoya University, Medical Department release new data on glioma

Head and Neck Cancer - Studies from J.K. Salama et al add new findings in the area of head and neck cancer

Head and Neck Cancer - Study results from Taipei Veterans General Hospital in the area of head and neck cancer published

Immunization - Study findings from E.H. Tay et al provide new insights into immunization

Kidneys - Studies from S. Marur and co-authors have provided new information about kidneys

Mantle Cell Lymphoma - Investigators at Columbia University target mantle cell lymphoma

Melanoma - New melanoma research from New York University, Medical Department discussed

Melanoma - Reports outline melanoma research from N. Penel and colleagues

Myelodysplastic Syndrome - Reports on myelodysplastic syndrome findings from C. Ravoet and co-researchers provide new insights

Myeloma - Researchers from University of Arkansas discuss findings in myeloma

Myeloma - Scientists at University of Leipzig discuss research in myeloma

Non-Small Cell Lung Cancer - Studies by D. Rossi and co-authors describe new findings in non-small cell lung cancer

Non-Small Cell Lung Cancer - Studies by T. Tanvetyanon and co-authors describe new findings in non-small cell lung cancer

Polycythemia Vera - Study results from J.J. Kiladjian and colleagues in the area of polycythemia vera published

Prostate Cancer - New prostate cancer research has been reported by scientists at Oregon Health & Science University

Prostate Cancer - Research conducted at G. Sonpavde and co-researchers has updated our knowledge about prostate cancer

Prostate Cancer - Research from G. Attard and co-authors yields new data on prostate cancer

Prostate Cancer - Research on prostate cancer detailed by scientists at Georgetown University

Renal Cell Carcinoma - Reports from University of Texas advance knowledge in renal cell carcinoma

Renal Cell Carcinoma - Researchers at University of Texas target renal cell carcinoma

Small Cell Lung Cancer - New findings reported from Johns Hopkins University describe advances in small cell lung cancer

Soft Tissue Sarcoma - Findings from V. Ferraresi and co-authors provide new insights into soft tissue sarcoma

Solid Cancer - Researchers from University of New Mexico report recent findings in solid cancer

Thrombocytopenia - Study findings from Emory University broaden understanding of thrombocytopenia

Vaginitis - New data from F. Peixoto et al illuminate research in vaginitis

Breast Cancer Therapy - Researchers from Edouard Herriot Hospital publish findings in breast cancer therapy

Breast Cancer Therapy - Studies from R. Addeo and co-authors have provided new information about breast cancer therapy

Cancer Prevention - Reports from Charles University, Faculty of Pharmacy highlight recent research in cancer prevention

Chronic Obstructive Pulmonary Disease Therapy - Karolinska University describes research in chronic obstructive pulmonary disease therapy

Lung Cancer Therapy - Recent studies from Hershey Medical Center, Department of Medicine add new data to lung cancer therapy

Pancreatic Cancer Therapy - Scientists at Chiba University, Department of General Surgery discuss research in pancreatic cancer therapy

Prostate Cancer - Data on prostate cancer published by researchers at University of Pittsburgh, Department of Urology

Acute Myeloid Leukemia - Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium

Adverse Drug Reactions - CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

Affymax, Inc. - Affymax Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients

Allergies - Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients

Alzheimer Disease - Ceregene Phase 2 Clinical Trial for Alzheimer's Disease to be Funded by $5.4 Million Grant From National Institutes of Health

Amarin Corporation plc - Amarin CEO Featured on CEOcast.Com

ARYx Therapeutics Inc. - ARYx Therapeutics Inc. Completes Enrollment in EmbraceAC Study -- Phase 2/3 Clinical Trial Comparing Anticoagulant ATI-5923 Against Warfarin

Atrial Fibrillation - Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation

Bavarian Nordic A/S - Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE

Bayhill Therapeutics, Inc. - Bayhill Therapeutics and the Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes

Bioengineering - BioMarin Announces Initiation of Clinical Assessment Program for Morquio a Syndrome

Biologics - Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results

Biopharmaceuticals - PAREXEL Expands Pioneering Asian Ethnobridging Expertise

Biotechnology Business - Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors

Biothera, the Immune Health Company - Biothera to Present Imprime PGG Clinical Trial Results at the International Society for Biological Therapy of Cancer

Breast Cancer - Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer

Cancer - Gleevec holds potential as first drug to successfully treat neurofibromatosis, Indiana University School of Medicine scientists report

Cancer - OncoMed Pharmaceuticals Completes Series B Financing

Canopus BioPharma, Inc. - Working with U.S. Department of Defense, Canopus BioPharma Announces Phase II Human Clinical Trial for Innovative Hepatitis C Drug, CB5300

Celldex Therapeutics, Inc. - Celldex Presents Results from Phase 1 Studies of CDX-1307 with GM-CSF

Clinical Trial Research - Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial

Clinical Trial Research - Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin

Clinical Trial Research - Repligen Reports Second Quarter Fiscal Year 2009 Financial Results

ConjuChem Biotechnologies Inc. - ConjuChem Provides Development Update

Diabetes - Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients

DNA Vaccines - U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant

Drug Resistance - Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD

Gemin X Pharmaceuticals - Gemin X Announces Data Presentation for its Novel, Targeted Cancer Therapy Obatoclax at the 26th Chemotherapy Foundation Symposium

Genentech, Inc. - Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer

Genzyme Corp. and Osiris Therapeutics, Inc. - Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products

GTC Biotherapeutics, Inc. - GTC Biotherapeutics Reports Third Quarter 2008 Financial Results

Heart Failure - Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008

HIV/AIDS - Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results

HIV/AIDS - Tibotec Presents Interim Findings for Tmc435, an Investigational Genotype 1 Hepatitis C Treatment, At the Aasld Liver Meeting 2008

Human Genome Sciences, Inc. - Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments

Immunization - NasVax Commences a Phase I/ IIa Dose-Optimization Clinical Study of VaxiSomeTM-Adjuvanted Influenza Vaccine the company presents positive results for VaxiSome in its initial clinical study with intramuscular dosing.

Immunotherapy - Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium

Kidney Disease - Medgenics Announces Encouraging Preliminary Data for Phase I/II Clinical Trial of EPODURE In Renal Anemia

Obesity and Diabetes - Derma Sciences Enrolls First Patient in DSC127 Phase II Study

Oncolytics Biotech Inc. - Oncolytics Biotech Inc. Announces 2008 Third Quarter Results

Oncolytics Biotech Inc. - Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data

Optimer Pharmaceuticals, Inc. - Optimer Pharmaceuticals Reports Third Quarter 2008 Financial Results

Osiris Therapeutics, Inc. - Osiris Therapeutics Reports Third Quarter 2008 Financial Results

Pediatrics - MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine

Pediatrix Medical Group, Inc. - Pediatrix to Present at Oppenheimer's 19th Annual Healthcare Conference

Pharmos Corporation - Pharmos Corporation Reports 2008 Third Quarter Results

Post Traumatic Stress Disorder - Synosia Therapeutics Starts Phase IIa Trial of Nepicastat for Treatment of Post-Traumatic Stress Disorder (PTSD)

Progenics Pharmaceuticals, Inc. - Progenics Selects Small-Molecule Hepatitis C Drug Candidate for Clinical Development

Provectus Pharmaceuticals, Inc. - Provectus Pharmaceuticals Adds Fifth Center to Phase 2 Clinical Trial of PV-10

Safeguard Scientifics, Inc. - Safeguard Scientifics Announces Third Quarter 2008 Financial Results

Vertex Pharmaceuticals Incorporated - New Clinical Data Support Broad Profile for Telaprevir in Patients with Genotype 1 Hepatitis C Virus HCV Infection

ZIOPHARM Oncology, Inc. - ZIOPHARM Oncology Reports Third Quarter Financial Results

ZymoGenetics, Inc. - ZymoGenetics Presents Positive Interim Phase 1b Results in Hepatitis C

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx